Hagit Dafni

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth fa
    Hagit Dafni
    Department of Experimental Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Magn Reson Med 60:822-33. 2008
  2. ncbi Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy method
    Madhuri Sankaranarayanapillai
    Experimental Diagnostic Imaging, Imaging Physics, and Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Mol Imaging 7:92-100. 2008

Collaborators

  • James A Bankson
  • Madhuri Sankaranarayanapillai
  • Juri G Gelovani
  • William P Tong
  • Sabrina M Ronen
  • Marc S Ramirez
  • Suren Soghomonyan
  • Douglas Webb
  • Qing Yuan
  • Kumaralal Kaluarachchi
  • Ashutosh Pal
  • William G Bornmann

Detail Information

Publications2

  1. ncbi Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth fa
    Hagit Dafni
    Department of Experimental Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Magn Reson Med 60:822-33. 2008
    ..Our study therefore demonstrates that macromolecular DCE-MRI can be used to detect early vascular effects associated with response to therapy targeted to PDGFR, and provides insight into the role played by VEGF in anti-PDGFR therapy...
  2. ncbi Monitoring histone deacetylase inhibition in vivo: noninvasive magnetic resonance spectroscopy method
    Madhuri Sankaranarayanapillai
    Experimental Diagnostic Imaging, Imaging Physics, and Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Mol Imaging 7:92-100. 2008
    ..However, difference in tumor size reached significance only on day 6 of treatment. Thus, this work identifies BLT as a potential molecular imaging agent for the early noninvasive MRS detection of HDAC inhibition in vivo...